Poxvirus-based active immunotherapy synergizes with immune checkpoint inhibitors to cause tumor regression and extend survival in preclinical models of cancer

Detalles Bibliográficos
Autores principales: Foy, Susan P, Rountree, Ryan B, Cote, Joseph, dela Cruz, Tracy, Gordon, Evan, Trent, Erica, Franzusoff, Alex, Breitmeyer, James B, Mandl, Stefanie J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288427/
http://dx.doi.org/10.1186/2051-1426-2-S3-P124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288427/
http://dx.doi.org/10.1186/2051-1426-2-S3-P124

Ejemplares similares